뒤로
Epigenomics AG(EPGNF) 가격
EPGNF 주가 차트
EPGNF 수입
Epigenomics AG
$1.12
0%
$0
종가: Jan 16, 16:00:00 GMT-5
$1.12
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$1.12
시가
$1.12
일일 범위
$1.12 - $1.12
52주 범위
$0.79 - $1.12
거래량
380
평균 거래량
0
EPS(TTM)
-3.69
배당수익률
--
시가총액
$982.1K
EPGNF란 무엇인가요?
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 3 full-time employees. The company went IPO on 2004-07-19. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.